Nektar Therapeutics (NKTR) Exchange Rate Effect (2010 - 2025)
Nektar Therapeutics (NKTR) recorded quarterly Exchange Rate Effect of $1000.0 in Q3 2025, down 83.33% quarter-over-quarter from $6000.0 in Q2 2025, and up 103.57% on a YoY basis from $491.23 in Q3 2024.
Nektar Therapeutics (NKTR) Exchange Rate Effect (2010 - 2025) Analysis & Trends
Nektar Therapeutics' Exchange Rate Effect history runs 16 years deep, the most recent figure standing at $1000.0 for Q3 2025.
- In Q3 2025, Exchange Rate Effect rose 103.57% year-over-year to $1000.0; the TTM figure through Mar 2026 stood at $7000.0 (up 133.33% YoY), while the FY2025 annual figure was $6000.0, up 250.0% from the prior year.
- Exchange Rate Effect was $1000.0 for Q3 2025 at Nektar Therapeutics, down from $6000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $107000.0 in Q2 2023 to a low of -$295000.0 in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$18684.2 across 5 years, with a median of -$8000.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect plunged 1080.0% in 2022, then jumped 700.0% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at -$10000.0 in 2021, then surged by 650.0% to $55000.0 in 2022, then tumbled by 85.45% to $8000.0 in 2023, then jumped by 312.5% to $33000.0 in 2024, then slumped by 96.97% to $1000.0 in 2025.
- The last three Exchange Rate Effect figures came in at $1000.0 (Q3 2025), $6000.0 (Q2 2025), and -$1000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Nektar Therapeutics | 1.51 Bn | 939.55 Mn | 3.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | 33,000.00 |
| Dec 31, 2024 | 33,000.00 |
| Sep 30, 2024 | -28,000.00 |
| Sep 30, 2024 | -28,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | -8,000.00 |
| Mar 31, 2024 | -8,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Sep 30, 2023 | -98,000.00 |
| Sep 30, 2023 | -98,000.00 |
| Jun 30, 2023 | 107,000.00 |
| Jun 30, 2023 | 107,000.00 |